Study name |
The effect of dydrogesterone and micronized progesterone on threatened abortion |
Methods |
2‐arm active‐controlled randomised trial. |
Participants |
Pregnant women with a gestational age 6 to 13 weeks and observed fetal heart rate, vaginal bleeding, absence of uterine and fetal anomalies. Exclusion criteria include breast carcinoma, severe liver problems, genital carcinoma, thromboembolic disorders, epilepsy, diabetes, hypertension. |
Interventions |
10 mg dydrogesterone, twice daily until 1 week after bleeding versus 100 mg progesterone, twice daily until 1 week after bleeding. |
Outcomes |
Preeclampsia; gestational diabetes; preterm labor; low birthweight; abortion under 20 weeks of pregnancy. |
Starting date |
22‐Oct‐2019 |
Contact information |
pakniat110@yahoo.com |
Notes |
|